Has Ivan Ayala, MD received payments from drug or device companies?

Yes. Drug and device makers reported $7,300 in general payments to Ivan Ayala, MD across 77 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ivan Ayala, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ivan Ayala, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ivan Ayala, MD

Cardiovascular Disease · Plantation, FLNPI 1497830897

Payments from drug & device makers

$7,300in general payments, 2019–2025

Across 77 payments — averaging $94.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Atricure, Inc.$3K
Heartflow, Inc.$2K
Abbott$966
Medtronic$288
Edwards Lifesciences$155
Abiomed$133
plus $752 from 8 others

What the payments were for

Food & beverage$7,300100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Atricure, Inc.	23	$3,019
Heartflow, Inc.	31	$1,987
Abbott	8	$966
Medtronic(2 entities)	3	$288
Edwards Lifesciences	1	$155
Abiomed	1	$133
Silk Road Medical, Inc.	1	$129
Elutia, Inc.	1	$126
Siemens Medical Solutions USA, Inc.	1	$124
Boston Scientific	1	$118
Cleerly, Inc.	1	$102
Cvrx, Inc.	2	$74
GE HealthCare	2	$56
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	1	$23

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,300 in reported general payments places this provider in the 65th percentile of 1,740 cardiovascular disease providers in Florida.

See all cardiovascular disease providers in Florida →

Medicare billing

Part B allowed, 2024

$159,220

Medicare patients

212

Services billed

4,057

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Plantation

Michael KorenGainesville$31M
Seth BaumBoca Raton$11.1M
Alexis GutierrezHialeah$8M
Eric SpivackAventura$7.1M
William OneillNaples$4.6M
Rafik AbadierInverness$4.4M
Alvaro MurciaPembroke Pines$4M
David HotchkissPort Charlotte$4M
Ferris GeorgeSt Augustine$3.8M
Duccio BaldariWellington$3.5M

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →